Cutler Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-311
| Closed | -$14K | – | 4041 |
|
|
2023
Q3 | $14K | Sell |
311
-4
| -1% | -$305 | ﹤0.01% | 2285 |
|
|
2023
Q2 | $30K | Buy |
315
+125
| +66% | +$13.6K | ﹤0.01% | 1604 |
|
|
2023
Q1 | $21K | Sell |
190
-5
| -3% | -$541 | ﹤0.01% | 1896 |
|
|
2022
Q4 | $21K | Hold |
195
| – | – | ﹤0.01% | 2186 |
|
|
2022
Q3 | $25K | Hold |
195
| – | – | ﹤0.01% | 2438 |
|
|
2022
Q2 | $13K | Hold |
195
| – | – | ﹤0.01% | 3014 |
|
|
2022
Q1 | $27K | Sell |
195
-115
| -37% | -$17.7K | ﹤0.01% | 2793 |
|
|
2021
Q4 | $51K | Sell |
310
-88
| -22% | -$14K | ﹤0.01% | 2391 |
|
|
2021
Q3 | $55K | Buy |
398
+238
| +149% | +$46.6K | ﹤0.01% | 2434 |
|
|
2021
Q2 | $76K | Buy |
160
+115
| +256% | +$48.5K | ﹤0.01% | 2118 |
|
|
2021
Q1 | $18K | Hold |
45
| – | – | ﹤0.01% | 3301 |
|
|
2020
Q4 | $22K | Sell |
45
-284
| -86% | -$166K | ﹤0.01% | 2622 |
|
|
2020
Q3 | $186K | Sell |
329
-201
| -38% | -$66.8K | 0.01% | 945 |
|
|
2020
Q2 | $50K | Hold |
530
| – | – | ﹤0.01% | 1749 |
|
|
2020
Q1 | $37K | Hold |
530
| – | – | ﹤0.01% | 1909 |
|
|
2019
Q4 | $36K | Hold |
530
| – | – | ﹤0.01% | 1858 |
|
|
2019
Q3 | $42K | Hold |
530
| – | – | ﹤0.01% | 1671 |
|
|
2019
Q2 | $34K | Hold |
530
| – | – | ﹤0.01% | 1829 |
|
|
2019
Q1 | $72K | Buy |
530
+11
| +2% | +$1.34K | 0.01% | 1202 |
|
|
2018
Q4 | $46K | Hold |
519
| – | – | ﹤0.01% | 1527 |
|
|
2018
Q3 | $78K | Hold |
519
| – | – | 0.01% | 1339 |
|
|
2018
Q2 | $89K | Sell |
519
-50
| -9% | -$8.17K | 0.01% | 1223 |
|
|
2018
Q1 | $83K | Hold |
569
| – | – | 0.01% | 1319 |
|
|
2017
Q4 | $115K | Buy |
569
+45
| +9% | +$9.24K | ﹤0.01% | 1286 |
|
|
2017
Q3 | $168K | Sell |
524
-216
| -29% | -$59K | 0.01% | 1288 |
|
|
2017
Q2 | $167K | Sell |
740
-20
| -3% | -$4.11K | 0.01% | 1428 |
|
|
2017
Q1 | $171K | Buy |
760
+10
| +1% | +$2.03K | 0.01% | 1307 |
|
|
2016
Q4 | $148K | Buy |
750
+683
| +1,019% | +$149K | 0.01% | 1565 |
|
|
2016
Q3 | $16K | Buy |
+67
| New | +$23.5K | ﹤0.01% | 3658 |
|
|
2016
Q2 | – | Sell |
-197
| Closed | -$116K | – | 7011 |
|
|
2016
Q1 | $104K | Buy |
+197
| New | +$103K | 0.01% | 1568 |
|
Other funds holding MCRB
FP
Cutler Group's MCRB Position: Q4 2023 in Review
Cutler Group sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 311 shares — an estimated $14K sold.
Cutler Group first reported a position in MCRB in Q1 2016 and held it in 30 quarters. The position peaked at $186K in Q3 2020. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.
- Cutler Group reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
- Cutler Group sold 311 Seres Therapeutics shares in Q4 2023, an estimated $14K.
- Cutler Group first reported a position in Seres Therapeutics in Q1 2016 and held it in 30 quarters.
- Cutler Group's Seres Therapeutics position peaked at $186K in Q3 2020.
- 102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.
Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.